Stocks · Health care · Pharmaceutical Preparations

Regeneron Pharmaceuticals

REGN Clue Score51
United States Fiscal year ends December CIK 0000872589 Results filed 30 Oct 2026

What the insiders did Scheduled selling only

By person

20 insiders · 51 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
George L Sing
Director
—
$20.38M (9) scheduled
−$20.38M
27,297
0.027%
$26.51M
−4.0%
Christine A Poon
Director
—
$7.59M (6) scheduled
−$7.59M
5,219
0.005%
$5.07M
+140.3%
Huda Y Zoghbi
Director
—
$7.22M (2) scheduled
−$7.22M
1,703
0.002%
$1.65M
+23.2%
Joseph J Larosa
EVP General Counsel and Secret
—
$4.31M (2) scheduled
−$4.31M
44,726
0.044%
$43.43M
+16.6%
Andrew J Murphy
Co-Chief Scientific Officer
—
$3.20M (27) scheduled
−$3.20M
51,193
0.050%
$49.71M
−2.9%
Michael S Brown
Director
—
$1.69M (1) scheduled
−$1.69M
12,865
0.013%
$12.49M
+2.6%
Marion McCourt
EVP Commercial
—
$984.19K (1) scheduled
−$984.19K
11,090
0.011%
$10.77M
−15.7%
Kathryn Guarini
Director
—
$360.00K (1) scheduled
−$360.00K
603
<0.001%
$585.55K
+113.8%
George Yancopoulos
Bd. Co-Chair, President & CSO
—
—
—
310,460
0.302%
$301.48M
+5.1%
Leonard S Schleifer
Bd. Co-Chair, President & CEO
—
—
—
214,523
0.209%
$208.31M
+8.9%
Neil Stahl
EVP Research and Development
—
—
—
48,829
0.047%
$47.42M
−1.6%
Christopher R. Fenimore
EVP Finance CFO
—
—
—
25,249
0.025%
$24.52M
+34.1%
Plew Daniel P Van
EVP & General Mgr, Industrial
—
—
—
21,673
0.021%
$21.05M
+6.4%
Arthur F Ryan
Director
—
—
—
17,303
0.017%
$16.80M
−1.6%
Joseph L Goldstein
Director
—
—
—
6,703
0.007%
$6.51M
+5.0%
Jason Pitofsky
SVP Controller
—
—
—
4,272
0.004%
$4.15M
+1.6%
N Anthony Coles
Director
—
—
—
1,714
0.002%
$1.66M
+23.0%
Bonnie L Bassler
Director
—
—
—
1,703
0.002%
$1.65M
+23.2%
Craig B. Thompson
Director
—
—
—
775
<0.001%
$752.57K
+70.7%
David P Schenkein
Director
—
—
—
603
<0.001%
$585.55K
+113.8%